PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-May-2022 RG6501 (OpRegen®) Phase 1/2a Clinical Results Support the Potential for OpRegen to Slow, Stop or Reverse Disease Progression in Geographic Atrophy Secondary to Age-Related Macular Degeneration Businesswire
03-May-2022 Revance to Release First Quarter Financial Results on Tuesday, May 10, 2022 Businesswire
03-May-2022 Danimer Scientific and Kemira Expand Exclusive Partnership to Commercialize Fully Biobased Barrier Coatings Businesswire
03-May-2022 Massive Bio and Amber Specialty Pharmacy Announce Nationwide Partnership to Revolutionize Digitally Enabled Oncology Clinical Trial Recruitment through AI Technology Platform Businesswire
03-May-2022 TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool® Device for the Treatment of Concussions Businesswire
03-May-2022 Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer Businesswire
03-May-2022 NiKang Therapeutics and Hansoh Pharma Announce Strategic Collaboration and License Agreement for NKT2152 in Greater China Businesswire
03-May-2022 Discovery Life Sciences™ Further Validates Quality of its Biospecimen Solutions by Participating in VERIF.i®, Scientist.com’s Supplier Pre-assessment Program Businesswire
03-May-2022 Distributors Agree to Opioid Settlement With Washington State Businesswire
03-May-2022 BioXcel Therapeutics Announces First Patient Dosed in TRANQUILITY II Phase 3 Trial for Acute Treatment of Agitation in Patients with Alzheimer’s Disease BioXcel Therapeutics
03-May-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-May-2022 BD to Showcase its Deep Commitment to Drug Delivery Excellence at Pharmapack BD
03-May-2022 CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development CYTENA
03-May-2022 TOPTICA Renews its Brand Presence TOPTICA
03-May-2022 ADC Therapeutics to Host First Quarter 2022 Financial Results Conference Call on May 9, 2022 Businesswire
03-May-2022 United States Ophthalmic Compounding Pharmacies Industry Report to 2028 - Players Profiled Include Nora Apothecary, Lifecare Pharmacy, Avella Specialty Pharmacy and Triangle Compounding Pharmacy - ResearchAndMarkets.com Businesswire
03-May-2022 Orgenesis Led Consortium awarded EUR 4M European Innovation Council Pathfinder Grant Orgenesis
03-May-2022 Neuraxpharm pursues growth strategy for business in Switzerland Neuraxpharm
03-May-2022 Insights on the Asthma and COPD Drugs Global Market to 2030 - Key Players Include Novartis, Organon and Sanofi - ResearchAndMarkets.com Businesswire
03-May-2022 Global Systemic Scleroderma Treatment Market to 2028 - by Drug Class, Disease Type, Route of Administration, Distribution Channel, and Region - ResearchAndMarkets.com Businesswire